Skip to content

Efficacy of herbal solution in androgenic alopecia treatment

Comparison of topical herbal preparation with minoxidil in androgenic alopecia: double blind randomized clinical trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220626055283N1
Enrollment
60
Registered
2022-11-30
Start date
2022-11-11
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male androgenic alopecia. Androgenic alopecia, unspecified

Interventions

Intervention 1: Intervention group:Receiving topical herbal preparation (containing extracts of Adiantum capillus-veneris 1%, Centella asitica 0.5%, Ruta graveolense 0.5%, Emblica officinalis 5%). Int

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: All male patient between 18-45 years old with androgenic alopecia Patient satisfaction

Exclusion criteria

Exclusion criteria: Endocrine disorder Using zinc and iron supplement Renal disease Malnutrition and iron deficiency anemia Thyroid disorder Systemic disorder such as lupus Other causes of alopecia like alopecia areata and scar alopecias Using drugs lead to alopecia like anti-hypertensive agents or NSAIDs History of dermatologic or systemic malignancy Psychiatric disorders Consumption of alcohol History of consumption of finasteride within 6 months ago

Design outcomes

Primary

MeasureTime frame
Hair count. Timepoint: Evaluation of hair count with trichoscopy in 0, 8, 16 , 24 weeks of trial. Method of measurement: Efficacy of herbal solution (Adiantum Capillus-veneris, Centella asitica, Rutagraveolense, Emblica officinalis) on androgenic alopecia and examine hair count with trichoscopy.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Mahdieh Toosi

Mashhad University of Medical Sciences

Tousimh991@mums.ac.ir+98 51 3802 2031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026